Source: U.S. Food and Drug Administration submitted to
ENHANCING THE SAFETY OF HIGH PRESSURE PROCESSED JUICES
Sponsoring Institution
National Institute of Food and Agriculture
Project Status
COMPLETE
Funding Source
Reporting Frequency
Annual
Accession No.
1012343
Grant No.
2017-67018-26230
Cumulative Award Amt.
$258,253.00
Proposal No.
2016-10306
Multistate No.
(N/A)
Project Start Date
Jun 1, 2017
Project End Date
Nov 30, 2020
Grant Year
2017
Program Code
[A1331]- Improving Food Safety
Recipient Organization
U.S. Food and Drug Administration
6502 S Archer Road
Bedford Park,IL 60501
Performing Department
Inst of Food Safety and Health
Non Technical Summary
The FDA Juice HACCP Rule (21 CFR Part 120) defines a 5-log reduction of the pertinent microorganism in juices to provide consumers an adequate level of protection from hazards related to fresh juices. The rule was based on NACMCF recommendations and centered on pasteurization or thermal processes to treat juices to deliver the necessary reduction of microorganisms. As new technologies became available, further studies were required. However, a number of studies have demonstrated loss of key beneficial nutrients with thermally treated juices. High pressure processing (HPP) has gained popularity because of its ability to inactivate foodborne pathogens and spoilage microorganisms, inactivate certain enzymes and extend the shelf-life of foods without the need to use chemical preservatives or heat. HPP is an effective process when applied correctly along with proper validation, but in a vacuum of clear regulatory guidance there has been some confusion among juice processors and regulators on how validation of HPP treated juices should be conducted and on the approach to methodology for assessing its effectiveness such as interference of juice matrix on microbiological methods. The proposed project will screen and evaluate various pathogens for HPP resistance, select strains for validation studies, assess the impact of processing conditions on microbial inactivation and evaluate the same under shelf-life abuse conditions. The outcomes will include: defining a safe harbor for HPP treated juices to control foodborne hazards using a risk-based approach; identification of methods to improve recovery, concentration and detection of microbial pathogens that will minimize the impact of juice matrices; and, develop low-cost efficient rapid detection tools that will quickly assess the safety of these juices. The outcomes will be disseminated through the development of validation guidance for HPP treated juices that will enhance the safety track record of HPP and HPP treated juices and provide key data for industry and regulators on the behavior of such juices from manufacturer to retailer to consumer.
Animal Health Component
70%
Research Effort Categories
Basic
20%
Applied
70%
Developmental
10%
Classification

Knowledge Area (KA)Subject of Investigation (SOI)Field of Science (FOS)Percent
7235010110050%
5015010202020%
5025010110010%
5025010302010%
7125010303010%
Goals / Objectives
HPP treated juices are required by the FDA Juice HACCP regulations to demonstrate the reduction of 5 log CFU/ml of the pertinent organism in the juice and even though HPP treated juices are currently available at retail, there is currently no consensus amongst industry, academia and government on a "standardized" validation protocol for juices to be treated by HPP. It appears there is no common approach to preparing bacterial strains for validation and challenge studies, no consensus on the HPP parameters required for treatment of the juices and no common approach on how shelf-life studies are conducted.The significance of the proposed project seeks to develop coordinated industry and regulatory science based consensus from the generated data and develop guidance on how validation should be conducted for HPP treated juices much like Clostridium botulinum challenge studies for extended shelf-life refrigerated foods described by Doyle (1991). The proposed project will develop "safe harbor" conditions i.e. defined as a recognized procedure that can be employed without further validation studies and approved as delivering a safe product and when implemented in industry, can be assured that the foodborne hazards are controlled during production and delivery of a safe product to consumers. The development of the "safe harbor" concept will allow government and regulators to better understanding of the technology to make regulations based on sound science and provide quicker turn-arounds for validation approvals. The proposed project will also provide guidance for industry laboratories or academia evaluating the microbiological safety of HPP treated juices to follow a reliable protocol to quickly detect and easily assess microbiological safety with confidence.The goal of the proposed project is as followsDevelop HPP validation guidelines and define "safe harbor" and processing critical limits to enhance the safety of HPP treated juices.The objectives of the project are as followsScreen bacterial isolates for HPP resistance, select final sets of bacterial isolates for validation studies and quantify the effect of juice matrices on bacterial inactivationDefine HPP parameters that affect inactivation of selected bacterial isolatesDetermine impact of recovery procedures on enrichment of target bacterial isolatesDefine protocol for shelf-life analysis of HPP treated juicesDevelop and disseminate guidance document for the HPP treated juices
Project Methods
The team proposes to address each of the objective in turn as the outcomes from each objective may be interlinked. There are many different juice types - single ingredients blends and multi-ingredients blends and fruit smoothies style blends with different water activities, pH, viscosity and particulates. For the purpose of this proposal, the team proposes working on high acid or acidified juices as low acid juices poses other microbiological challenges such as the risk of Clostridium botulinum. The team will work with a single ingredient juice e.g.orange juice or apple juice as a model juice. The juice will be sourced from a selected supplier with known and consistent characteristics such as pulp, °brix, titratable acidity and seasonality. Once the HPP conditions and pathogen inactivation protocols have been establish, a multi-ingredient juice blend such as apple and orange juice or a citrus juice with vegetable blend could be evaluated using the identified processing conditions to determine the impact of matrix on pathogen inactivation and factors that affect recovery and detection of pathogens during validation.Prior to starting work, the team will review all current literature to collate various HPP processing information and conditions. The advisory committee and industry will be polled to obtain the information. The information will be collated, data blinded and presented to stakeholders and for the project team to fine tune research plans that minimize overlaps.Objective 1 - Screen bacterial isolates for HPP resistance, select final sets of bacterial isolates for validation studies and quantify the effect of juice matrices on bacterial inactivationThe bacterial strains will be selected and evaluated for HPP resistance. Bacterial strains from known outbreaks or closely related outbreak strains will be used in the study. The selected strains will be evaluated for growth characteristics that may affect HPP resistance such as adapting them to acidic conditions and impact on survival in juices with various pH.Objective 2 - Define HPP parameters that affect inactivation of selected bacterial isolatesThe parameters used during HPP treatments could impact quality of the product and pathogen inactivation. Conditions such as product pH and water activity, processing temperature, amount of pressure and pressure hold times can affect process validation outcomes and overall successful implementation of the process. In this section, the minimum pressure and temperature required for inactivation of bacterial pathogens will be evaluated for a 5 log reduction. Bacterial strains will be inoculated into juices with various pH and HPP treated with varying HPP parameters. The impact of packaging materials i.e whether the juices are packed in flexible pouches or bottles will be evaluated.Objective 3 - Determine impact of recovery procedures on enrichment of target bacterial isolatesThe current FDA BAM methods for juices is not prescriptive for quantitative assessment of juices but rather qualitative assessment using enrichment media. We have over the years while conducting validation studies for HPP treated juices, observed enrichment media failing to detect the presence of pathogens when bacteriological media have shown colonies of the pathogen. For example, in orange juice E. coli O157:H7 colonies were detected on non-selective and selective VRBA agar but enrichment using 2X modified buffered peptone water (mBPW) did not detect E. coli O157:H7. It is possible that the juice matrix may have affected the composition of mBPW resulting in no detection of E. coli O157:H7. Similar observations were noted for previous validation using L. monocytogenes where L. monocytogenes was not detected by enrichment using Basal Listeria Enrichment Broth (BLEB) and L. monocytogenes colonies were observed on MOX agar.To address this issue, it is proposed that an enhanced sample preparation method be developed and evaluated to minimize the impact of juice matrix. Methodologies such as the use of centrifugation to pellet cells and washing the pellet with enrichment media prior to resuspension of pellet, dilution of juice matrix, evaluation of pH adjustments will be explored. The effect of refrigerated storage after HPP treatment for a certain period prior to recovery of bacteria inoculum will be evaluated on the ability of injured cells to be effectively recovered and quantitated.Objective 4 - Define protocol for shelf-life analysis of HPP treated juicesCurrent challenge testing of HPP treated juices involves a shelf-life analysis of the inoculated juice post-HPP treatment that includes either severe or moderate abuses, depending on the juice type. The shelf-life analysis is normally performed 1.5x that of the intended shelf-life i.e. if the HPP treated juice has an intended shelf-life of 30 days, the challenge study would last at least 45 days or 1.5x of intended shelf-life. During the shelf-life study, the FDA Juice HACCP has indicated that prolong storage at one temperature is not indicative of safety and should include abuses the juice may be subjected to from manufacture to consumer. However, the definitions of severe and moderate abuses are not well defined and many conducting such studies may not incorporate the necessary abuses during the shelf-life.We propose to conduct challenge shelf-life analysis based on risk assessment of the distribution and storage patterns in consultation with the industry and conditions in which the HPP juice may encounter so as to identify points of abuse. During shelf-life testing (based on 45 days example), inoculated samples (approx. 6 log cfu/ml) will be HPP treated and subjected to moderate abuse conditions as recommended by FDA Juice HACCP Rules and the maintenance of the 5 log reduction throughout shelf-life. At regular sampling intervals, samples will be removed from refrigerated storage and microbiologically tested and analyzed.Objective 5 - Develop and disseminate guidance document for the HPP treated juicesThe information (Objectives 1-5) will be compiled and discussed with the project advisory committee and FDA. Regular meetings will be conducted with all stakeholders and results disseminated via emails, webinars and secured shared drives (to be setup at project start). Project outcomes will be disseminated via industry trade forums such as The Juice Products Association Annual Technical Meeting, scientific meetings such as the Institute for Food Technologists and the International Association for Food Protection annual meetings. It is also proposed that the project team will get together with all stakeholders at an annual event for example a pre-meeting prior to the IFSH Annual Meeting in September that is attended by industry and government.The project team in consultation with FDA will review and draft documents for the advisory committee to review and for circulation to stakeholders for comments. The project team will list all pressure and time combinations along with other key processing parameters to help establish safe harbor conditions for HPP treated juices.?

Progress 06/01/17 to 11/30/20

Outputs
Target Audience:The target audience will the the food industry who manufacture and hold juices and beverages, testing laboratories that conduct challenge and validation studies and state and federal regulatory agencies enforcing Juice HACCP. Changes/Problems: Nothing Reported What opportunities for training and professional development has the project provided?The findings of the project was originally scheduled to be trial in a High Pressure Processing and validation workshop at the Institute for Food Safety and Health, IIT in April 2020. This workshop was to give training to industry users and laboratory scientists who conduct studies using HPP. The workshop will also provide an overview of how challenge studies should be conducted for HPP treated juices. However, the workshop was cancelled due to COVID-19 and rescheduled for late 2021/early 2022. A session in partnership with the Cold Pressure Council was scheduled in September 2020 but due to COVID-19, the session was rescheduled to September 2021. The findings of the project will be presented to industry members so that they understand how to interpret and conduct appropriate challenge studies for their juice products. The project findings were also presented at the virtual Food Safety Summit 2020 in the session Validation of Non-thermal Technologies and the information was well received. How have the results been disseminated to communities of interest?The results have been disseminated to the scientific communities via the International Association for Food Protection annual scientific meetings and the IAFP European Symposium. PhD candidate, Catherine Rolfe, was awarded 3rd Place in the 2019 IAFP Developing Scientist Award for her work. Similarly, the information was also shared with FDA and industry at the IFSH Juice and Beverage Safety Task Force annual meeting. We have three manuscript in preparation or under review and will make those manuscript available to interested parties once they are published. The industry engagement from juice manufacturers, HPP equipment manufacturers and regulators have been fantastic with active engagement during the course of the project. What do you plan to do during the next reporting period to accomplish the goals? Nothing Reported

Impacts
What was accomplished under these goals? The objectives for #3 was combined in part with objective #2 and #4 as the protocol for recovery were address in Objectives #2 and #3. The impact of recovery procedures post-HPP treatment were also addressed in Objective #2. The purpose of the project was to develop validation guidelines for HPP inactivation and post-HPP recovery of pressure resistant and matrix-adapted E. coli O157:H7, Salmonella spp., and Listeria monocytogenes in HPP-treated juices. Main objectives included: screen bacterial isolates for barotolerance and select isolates for validation studies, assess the effects of juice matrices and define HPP parameters, determine impact of recovery methods on enrichment procedures, define protocol for shelf-life analysis, and provide framework for guidance document related to HPP-treated juices. Ten strains of each microorganism were prepared in three growth conditions (neutral, cold-adapted, or acid-adapted) and assessed for barotolerance or sensitivity. Cold-adapted cells were prepared at 17°C. Acid-adapted cells were prepared in intermediate pH 5.0 broth. Approximately 6 log CFU/mL of bacterial strains were inoculated into buffer (pH 3.5). Pressure treatment applied at sublethal levels for the initial bacterial screening. Analyses were conducted 0h, 24h and 48h (4°C storage) post-HPP. Pressure resistant and sensitive strains from each (6 strains with neutral, cold-adapted, or acid-adapted growth conditions) were used to evaluate HPP inactivation with increasing pressure levels (200 - 600 MPa) in juice matrices (apple and orange). A 75-day shelf-life analysis was conducted on HPP-treated juices inoculated with acid-adapted resistant strains for each pathogen and examined for inactivation and recovery. Individual strains of E. coli O157:H7, Salmonella spp., and L. monocytogenes demonstrated significant (p <0.05) differences in reduction levels in response to pressure treatment in high acid environments. It was found that E. coli O157:H7 was the most barotolerant of the three microorganism in multiple matrices. Bacterial screening resulted in identification of pressure resistant strains E. coli O157:H7 TW14359, Salmonella Cubana, and L. monocytogenes MAD328, and pressure sensitive strains E. coli O15:H7 SEA13B88, S. Anatum, and L. monocytogenes CDC. HPP inactivation in juice matrices (apple and orange) confirmed acid adaptation as the most conservative preparation compared to neutrally grown and cold-adapted. Shelf-life studies conducted for 75 days in cold storage with mild temperature abuse reached a 5-log reduction in HPP-treated juices immediately following pressure treatment for L. monocytogenes MAD328, after 24 h in cold storage for S. Cubana, and after 4 days of cold storage for E. coli O157:H7 TW14359. Recovery of injured cells was observed for L. monocytogenes in orange juice but still maintained a 5-log reduction. These results suggest the preferred inoculum preparation for HPP validation studies is the use of acid-adapted, pressure resistant strains. At 586 - 600 MPa, critical inactivation (5-log reduction) was achieved during post-HPP cold storage, suggesting sufficient HPP lethality is reached at elevated pressure levels with a subsequent cold holding duration. The shelf-life studies concluded with unexpected results. The microorganism reoccurring during shelf-life studies for orange juice was L. monocytogenes which was previously thought to be the most sensitive to pressure application compared to E. coli O157:H7 and Salmonella spp. Further, modifications to the E. coli O157:H7 recovery and enrichment procedures in both apple and orange juice did not prove substantial for sublethally injured cells. Salmonella results were as predicted with continued loss in viability following pressure treatment and lack of recovery following refrigerated storage. Limited research has been conducted on the effects of pressure application on membrane permeability and injured cell recovery. The disruption of the cell membrane during HPP treatment may lead to altered response mechanisms against selective agents included for enrichment procedures. Pressure induced cell damage may allow for better recovery of injured cells that have undergone stress adaptations. A thorough understanding of the effects of high pressure on E. coli O157:H7 membrane structure and function is necessary to develop proper recovery mediums and procedure. In addition, exploration of how L. monocytogenes stress adaptation influences recovery during cold storage conditions would provide beneficial guidance for shelf-life applications. Further genetic studies would be advantageous to conceptualize the gene expression following acid adaptation, pressure treatment, and cold storage, especially in a complex juice matrix. In relation to guidance development, the information generated from the project is being synthesized into manuscript and guidance document are also being developed with FDA collaborators. Consumer interest in functional beverages and minimal processed juices has led to increasing research of juice products treated with minimal processing. HPP has been shown to provide effective inactivation of pertinent microorganisms in high acid juice products to comply with the FDA Juice HACCP rule in various studies. The current study demonstrated the variability associated with individual strains of E. coli O157:H7, Salmonella spp., and L. monocytogenes when treated in high acid food environments. The results of this research propose barotolerant and acid-adapted strains of juice-associated pathogens should be used in cocktail inoculations for validation studies of HPP-treated juice. A pressure level of 586 MPa achieved a 5-log reduction of E. coli O157:H7 after 4 days in cold storage for apple and orange juice, however, data suggests increasing pressure and increasing hold times may provide greater inactivation. Further research on target pressure and hold time combinations in relation to different juice types would be beneficial. Additional assessment of acid-adapted E. coli O157:H7 enrichment methodology from high acid juices would provide reassurance of complete inactivation.

Publications

  • Type: Conference Papers and Presentations Status: Accepted Year Published: 2020 Citation: Rolfe C, Lee A, Anderson N and Black G. (2020). Influence of acid adaptation, cold adaptation on barotolerance on survival of E. coli O157:H7, L. monocytogenes, and Salmonella spp. during HPP treatment of apple juice. J. Food Protect. 83:1-288.
  • Type: Conference Papers and Presentations Status: Accepted Year Published: 2020 Citation: Lee A. Novel processing technologies  Validation, Application, Regulation. Food Safety Summit Conference and Expo. Rosemont, IL, May 4-7, 2020.
  • Type: Theses/Dissertations Status: Accepted Year Published: 2020 Citation: Catherine Rolfe PhD thesis - submitted and degree awarded Dec 2020


Progress 06/01/18 to 05/31/19

Outputs
Target Audience:The target audience include juice and beverage companies both domestic and international who exports to USA or manufacture juices and beverages in USA, HPP toll processers, HPP equipment manufacturers. The project results have been presented at the Cold Pressure Council where members are from the juice and beverage industry. The results have been presented at scientific conferences and meetings such as IAFP Europe and IAFP Annual Meeting in USA. Changes/Problems: Nothing Reported What opportunities for training and professional development has the project provided?The project allowed for the professional development of PhD student, Catherine Rolfe and exposed her to several opportunities to present her work. She is a finalist at the 2019 IAFP Annual Meeting Developing Scientist competition. How have the results been disseminated to communities of interest?Yes. The results have been disseminated to industry partners and members of the Cold Pressure Council. The project was also pick up for a writeup by Food Quality and Safety magazine. What do you plan to do during the next reporting period to accomplish the goals?In the September 2019 meeting with industry partners to discuss the initial draft of the guidance document. IT will also help formulate subsequent research activities and streamline the work involved in objectives #3 and #4. Some work may be needed to use another juice matrix such as orange juice to confirm results seen in apple juice as orange juice has a different organic acid. The data will then lead to bacterial recovery procedures and if the recovery procedures are impacted by the juices. Similarly, establishing additional data using another juice with a different organic acid will allow better evaluation of survival or inactivation during a shelf-life study since the pertinent microorganism may change with a different organic acid. For example, in the apple juice study, E. coli O157:H7 seem to be the pertinent microorganism that survive post-HPP storage but not L. monocytogenes. However, in orange juice, the pertinent microorganism may change.

Impacts
What was accomplished under these goals? The objectives accomplished were objectives #1 and #2. During the second year of the project, data on individual strain behavior in combination with high pressure treatment in buffer and apple juice matrices were collected. Using the bacterial strain selection conducted in Year 1 of the project, growth of individual strains ofE. coliO157:H7,L. monocytogenes, andSalmonellaspp. in various trypticase soy broth with 0.6% yeast extract (TSBYE) conditions were collected (Table 1). The pH levels were recorded at the end of incubation in the presence of pH neutral TSBYE at 37°C (24 h incibation), acid-adapted growth conditions with pH 5.0 TSBYE at 37°C (24 h incibation forE. coliandSalmonella, 48 h incubation forL. monocytogenes), and cold-adapted growth conditions with neutral TSBYE at 17°C (48 h incubation). The most HPP resistant and most HPP sensitive strains tested to date from the culture collection for E, coli O157:H7, Salmonella spp. and Listeria monocytogenes were selected for further study in apple juice using bacterial cells derived from three different growth conditions - neutral pH growth medium, cold adapted cells and acid adapted cells, and pressure treated at 200 - 600 MPa. The samples were stored 24 and 48 h post HPP treatment and microbiological evaluated at 24 and 48h. E. coliO157:H7 exhibited barotolerance compared toSalmonellaspp. andL. monocytogenes. In BPW neutral growth conditions,E. coliO157:H7 strain TW14359 demonstrated resistance (<3 log reduction) andE. coliO157:H7 strain SEA13B88 was most sensitive. Acid-adaptedL. monocytogenesstrain MAD328 had <1 log reduction whileL. monocytogenesstrains CDC and ScottA were most sensitive in BPW.Salmonellaisolates grown in neutral and acid-adapted conditions had comparable results (<1.5 log reduction), while cold-adaptedS.Cubana andS. Montevideo showed resistance compared to other strains. Bacterial inactivation in apple juice showed similar strain inactivation to BPW but incremental barotolerance was observed. Progressive loss of viability occurred from all post-HPP storage samples.The currentresults suggest HPP is an effective inactivation method forE. coliO157:H7,L. monocytogenesandSalmonella, however, matrix composition, bacterial strain selection and preparation methods and process parameters can influence overall inactivation levels.

Publications

  • Type: Conference Papers and Presentations Status: Accepted Year Published: 2019 Citation: International Association for Food Protection (IAFP) European Symposium, April 25, 2019, Nantes, France  Bacterial strain selection for the validation of high-pressure-treated juices [Technical Presentation]
  • Type: Other Status: Published Year Published: 2019 Citation: Cold Pressed Juice is a Hot Trend, May 23, 2019, Food Quality and Safety (https://www.foodqualityandsafety.com/article/cold-pressed-juice-trend/?singlepage=1)
  • Type: Conference Papers and Presentations Status: Accepted Year Published: 2019 Citation: 2019 Cold Pressure Council Annual Conference, March 26-27, 2019 - Update on the Juice Task Force  Progress for All [Invited Presentation] (pmmi.docsend.com/view/qdzz4wp)


Progress 06/01/17 to 05/31/18

Outputs
Target Audience:In Sept 2017, the project team interacted with the External Advisory Board, comprising industry members,Juice Product Association and FDA, to discuss and refine project plans and protocols and to ensure outcomes of the work stayed relevant to the industry. The project was also part of the larger IFSH Juice and Beverage Safety Task Force and as a whole, agreed to screen bacterial strains currently used in challenge and validation studies for high pressure processed juices. The discussion resulted in Dr. Lee presenting the project to members of the Juice Product Association Annual Meeting in November 2017 at Atlanta. Changes/Problems: Nothing Reported What opportunities for training and professional development has the project provided?The current project provided training and professional development for a PhD candidate, Ms. Catherine Rolfe. How have the results been disseminated to communities of interest?The results have been discussed with FDA. The project team will present the data in the coming IFSH Juice and Beverage Safety Task Force meeting on 25 Sept 2017 at the Marriott South West Chicago, Burr Ridge, IL as part of the IFSH Annual Meeting. A depper dive on the results obtained to date will be presented to the High Acid Workgroup within the Task Force and next steps of the project will also be discussed. What do you plan to do during the next reporting period to accomplish the goals?The project team intends to continue working through the objectives of the projects. Work on bacterial strain screening occured using a buffered system and model juice using a low pH high acidsingle strength example of apple juice and another using high pH (
Impacts
What was accomplished under these goals? Screen bacterial isolates for HPP resistance, select final sets of bacterial isolates for validation studies and quantify the effect of juice matrices on bacterial inactivation In the first year of the project, Objective 1 on screening bacterial isolates for HPP resistance or barotolerance was conducted with 15 bacterial isolates comprising ofE. coliO157:H7 (F4546, M-11-0450i-1, Sakai, SEA13B88, and TW14359),Salmonellaspp. (Anatum, Cubana, Montevideo, Newport J1894, Saintpaul, and Typhimurium) andL. monocytogenes(1838, CDC, F2365, MAD328, and ScottA) strains.Pressure resistance was determined through inoculation into buffered peptone water (BPW) adjusted to pH 3.5 ± 0.1 using hydrochloric acid (HCl) at an inoculum level of approximately 6 log cfu/mL followed by sublethal pressure treatment, 500 MPa forE. coliO157:H7 strains and 200 MPa forSalmonellaspp.andL. monocytogenesstrains, for 180 seconds with an initial temperature of 4°C. Analysis was performed immediately following pressure treatment, 24h and 48h after pressure treatment (stored in 4°C) to allow for recovery of sublethally injured cells. Evaluation of matrix-adapted strains was also performed by growing the bacterial inoculum in three different conditions: trypticase soy broth with 0.6% yeast extract (TSBYE) at pH 7 incubated in 37°C overnight, TSBYE at pH 7 incubated in a 17°C waterbath for 48h, and TSBYE at pH 5 incubated in 37°C overnight (48h forL. monocytogenesstrains). TheE. coliO157:H7 strains demonstrated the most barotolerant of the three microorganisms (Figure 1). Following pressure treatment at 500 MPa with growth conditions in pH neutral broth and 37°C incubation overnight, theE. coliO157:H7 TW14359 strain demonstrated the greatest resistance with a 2.94 log cfu/mL reduction after day-of analyses.Under equal conditions,E. coliO157:H7 SEA13B88 showed to be the most sensitive with 5.75 log cfu/mL reduction.In growth conditions for acid adaptation, similar results were observed withE. coliO157:H7 TW14359 demonstrating the most resistance (3.62 log cfu/mL reduction) andE. coliO157:H7 SEA13B88 demonstrating the highest sensitivity (5.82 log cfu/mL reduction). For the cold-adapted cells,E. coliO157:H7 Sakai showed the greatest resistance towards high pressure with 4.12 log cfu/mL reduction after day-of analyses.E. coliO157:H7 SEA13B88 continued to show the highest sensitivity. Figure 1.Effect of HPP on inactivation ofE. coliO157:H7 grown in various growth conditions of (a) 37°C in pH neutral TSB, (b) 17°C in pH neutral TSB, and (c) 37°C in pH 5 TSB. HPP treatments were conducted at 500 MPa for 180s at an initial temperature of 4°C with analyses performed following treatment. TheSalmonellaspp. isolates showed dissimilarities compared to theE. coliO157:H7 andL. monocytogenesstrains with notable differences between the neutral and acid-adapted cells compared to the cold-adapted. A sublethal pressure of 200 MPa was used in order to recoverSalmonellaspp. after HPP treatment.Salmonellaspp. grown in neutral broth with incubation overnight at 37°C showed minimal variance between the strains,S.Cubana demonstrated the highest resistance (0.82 log cfu/mL reduction) andS.Anatum was the most sensitive to pressure (1.32 log cfu/mL reduction) following day-of analyses. Using acid-adapted cells,S.Anatum andS.Cubana were most barotolerant with similar log reductions of 0.66 log cfu/mL and 0.68 log cfu/mL, respectively (Figure 2). The least resistant strains wereS.Newport J1894 with 1.09 log cfu/mL reduction andS.Typhimurium with 1.07 log cfu/mL reduction. An increase in loss of viability was observed when cold-adapted cells were used whereS.Montevideo demonstrated the highest resistance with 3.51 log cfu/mL reduction andS.Saintpaul was the most sensitive with 4.68 log cfu/mL reduction. Figure 2.Effect of HPP on inactivation ofSalmonellaspp. grown in various growth conditions of (a) 37°C in pH neutral TSB, (b) 17°C in pH neutral TSB, and (c) 37°C in pH 5 TSB. HPP treatments were conducted at 200 MPa for 180s at an initial temperature of 4°C with analyses performed following treatment. ForL. monocytogenesstrains, pressure was applied at 200 MPa to achieve a sublethal treatment.L. monocytogenesgrown in neutral broth and incubated overnight at 37°C showed the highest resistance to 200 MPa withL. monocytogenesMAD328 being the most resistant with 2.41 log cfu/mL reduction and the most sensitive strain beingL. monocytogenesCDC with 4.06 log cfu/mL reduction after day-of analyses (Figure 3). Similar behavior was observed from the acid-adapted cells.L. monocytogenesMAD328 demonstrated barotolerance andL. monocytogenesScottA demonstrated sensitivity with reductions of 0.97 log cfu/mL and 3.43 log cfu/mL, respectively. However, inoculum levels of 6 log were difficult to achieve in an acidic growth environment. Average control inoculum of acid-adaptedL. monocytogenesranged from 5.36 to 6.05 log cfu/mL. The cold-adapted cells presented an alternative pattern withL. monocytogenes1838 showing the highest resistance at 0.91 log cfu/mL reduction andL. monocytogenesScottA least resistant with 4.11 log cfu/mL reduction. Figure 3.Effect of HPP on inactivation ofListeria monocytogenesgrown in various growth conditions of (a) 37°C in pH neutral TSB, (b) 17°C in pH neutral TSB, and (c) 37°C in pH 5 TSB. HPP treatments were conducted at 200 MPa for 180s at an initial temperature of 4°C with analyses performed following treatment. For allE. coliO157:H7,Salmonellaspp. andL. monocytogenesstrains evaluated in this study, recovery analysis performed after 24h and 48h of cold storage (4°C) post-HPP treatment did not deliver higher yields of recovery. Progressive loss of viability was observed. Current work consists of additional trials using 100% apple juice from concentrate at a pH of 3.5 to assess the effect of a juice matrix compared to BPW. Pressure resistant and sensitive strains ofE. coliO157:H7 TW14359,E. coliO157:H7 SEA13B88,S.Cubana,S.Anatum,L. monocytogenesMAD328 andL. monocytogenesCDC will be used.

Publications

  • Type: Conference Papers and Presentations Status: Other Year Published: 2017 Citation: Enhancing the Safety of High Pressure Processed Juices and IFSH Juice and Beverage Safety Task Force, Juice Products Association Annual Meeting, Atlanta